NEUROCRINE BIOSCIENCES ANNOUNCES CONFERENCE CALL AND WEBCAST OF THIRD QUARTER 2019 FINANCIAL RESULTS

Conference Call and Webcast Scheduled for Monday, November 4 SAN DIEGO, Oct. 14, 2019 /PRNewswire/ - Neurocrine Biosciences, Inc. announced...

RECEIVING INSPECTION TECHNICIAN - RADIOMETER AMERICA INC. - CARLSBAD, CA

Maintain part files and accurately document the results of inspections and testing. If you aspire to be part of a purpose, performance...

 
 
 

PROJECT ADMINISTRATOR - THE SCRIPPS RESEARCH INSTITUTE - SAN DIEGO, CA

Experience in industry working as a liaison with relevant stakeholders preferably in the biotechnology and/or healthcare industries.From...

SCREENING FOR DIFFERENTIAL EXPRESSION OF GENES FOR RESISTANCE TO SITODIPLOSIS MOSELLANA IN BREAD WHEAT VIA BSR-SEQ ANALYSIS

Abstract Key message Five putative candidate genes for OWBM resistance in Chinese winter wheat ‘Jimai 24' were identified via BSR-seq...

 
 
 

UNLOCKING THE BIOCHEMICAL TREASURE CHEST WITHIN MICROBES

An international team of scientists has developed a genetic engineering tool that makes producing and analyzing microbial secondary...

102288 R&D ENGINEER 1

CLIMATE/ATMOS SCI/PHY OCEANOG Hiring Salary Range: $48,900 - $75,600 /yearFiling Deadline: Mon 10/28/2019...

 
 
 

NEW STUDY EVALUATES HAND-HELD DEVICE FOR NON-SURGICAL THERAPY OF KIDNEY STONES

COVANCE CLINICAL DEVELOPMENT LEAD TAKES THE REINS AT PHARM-OLAM

As Covance changes up its leadership amid a major change at the top of its parent company, one of its former execs has jumped ship...

 
 
 

YAMA GROUP - GLOBAL ACCOUNT MANAGER - ENCINITAS, CA

Attention to detail is a must! Provides input to fee development. Provides assistance related to agency/team/management policies and...

In New Tibetan Genome Assembly, Variants for Living at Altitude and the Imprint of Archaic DNA

IN NEW TIBETAN GENOME ASSEMBLY, VARIANTS FOR LIVING AT ALTITUDE AND THE IMPRINT OF ARCHAIC DNA

The high-altitude Tibetan Plateau. Photo by McKay Savage via Wikimedia Commons A recent bioRxiv preprint reports efforts to sequence...

 
 
 

AVEXIS INC.: ASSOCIATE DIRECTOR, BIOMETRICS/STATISTICS

AveXis Inc.: OverviewReady to join a team committed to developing and commercializing gene therapies for patients and families devastated...

ANTIBODY ENGINEERING & THERAPEUTICS US: DEC 09, 2019

Antibody Engineering & Therapeutics is the global meeting place for antibody science, technology and networking - event brings 1000+...

 
 
 

KITE PHARMA: SENIOR SITE PLANNER

Kite Pharma: Kite, a Gilead Company, is a commercial-stage biopharmaceutical company focused on the development and commercialization...

QUANTIFYING MECHANISMS IN NEURODEGENERATIVE DISEASES USING CANDIDATE MECHANISM PERTURBATION AMPLITUDE ALGORITHM

Literature derived knowledge assemblies have been used as an effective way of representing biological phenomenon and understanding...

 
 
 

DYNAMICS RECONSTRUCTION AND CLASSIFICATION VIA KOOPMAN FEATURES

Abstract Knowledge discovery and information extraction of large and complex datasets has attracted great attention in wide-ranging...

AN APPLICATION OF MACHINE LEARNING WITH FEATURE SELECTION TO IMPROVE DIAGNOSIS AND CLASSIFICATION OF NEURODEGENERATIVE DISORDERS

The analysis of health and medical data is crucial for improving the diagnosis precision, treatments and prevention. In this field,...

 
 
 

METACELL: ANALYSIS OF SINGLE-CELL RNA-SEQ DATA USING K-NN GRAPH PARTITIONS

ScRNA-seq profiles each represent a highly partial sample of mRNA molecules from a unique cell that can never be resampled, and robust...

 
 
 
BIO's Week with Food and Ag Leaders

BIO'S WEEK WITH FOOD AND AG LEADERS

Meatless Burgers. Gene edited crops. Changing diets. Nothing was off the table this week as BIO engaged in two pivotal discussions...

Review: Long-Read Sequencing Helps Uncover Genetic Basis for Rare Disease

REVIEW: LONG-READ SEQUENCING HELPS UNCOVER GENETIC BASIS FOR RARE DISEASE

A new review article nicely sums up the utility of long-read sequencing for solving rare diseases that cannot be explained by other...